Victorine Lorette YIMGANG

Dr. Victorine Lorette YIMGANG

orcid

Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
26 December 2023 in Drugs and Drug Candidates
Verified
Journal Article
Open access
PDF file
LTLoic Franklin Tchinda Taghu
Loic Franklin Tchinda Taghu
PBPone Kamdem Boniface
Pone Kamdem Boniface
VNVincent Ngouana
Vincent Ngouana
TYTanka Zuriatou Zuriatou Yajeh
Tanka Zuriatou Zuriatou Yajeh
VYVictorine Lorette YIMGANG
Victorine Lorette YIMGANG
FBFabrice Fekam Boyom
Fabrice Fekam Boyom
The development of antimicrobial resistance has increased the prevalence of infectious diseases, causing a global health problem that accounts for over 4.95 million deaths worldwide annually. The side effects associated with current antibiotics prompt a crucial need to search for effective and safe antimicrobial agents. In this study, silver nanoparticles (AgNPs) were prepared by chemical reduction method using silver nitrates as a metallic precursor and Croton macrostachyus bark aqueous extract as a reducing and capping agent. The nanoparticles were further functionalized using C. macrostachyus-based activated carbon (CAC) to generate nanocomposites (CAC-AgNPs). The nanomaterials were characterized by ultraviolet-visible (UV–vis) absorption spectra and Fourier transform infrared (FTIR) spectra. The antibacterial activity of the as-prepared nanomaterials was evaluated against an array of bacterial strains by microdilution method, whereas their cytotoxicity profile was evaluated using Vero cells (human mammalian cells). Antibacterial mechanistic studies of active nanomaterials were carried out through bacterial growth kinetics, nucleic acid leakage tests, and catalase inhibition assays. As a result, the as-prepared nanomaterials exhibited antibacterial activity against an array of bacterial strains (minimum inhibitory concentration (MIC) range: 62.5 to 500 µg/mL), the most susceptible being Escherichia coli and Staphylococcus aureus. Cytotoxicity studies of the nanomaterials on Vero cells revealed that the nanocomposite (median cytotoxic concentration (CC50): 213.6 µg/mL) was less toxic than its nanoparticle (CC50 value: 164.75 µg/mL) counterpart. Antibacterial mechanistic studies revealed that the nanomaterials induced (i) bacteriostatic activity vis à vis E. coli and S. aureus and (ii) inhibition of catalase in these bacteria. This novel contribution regarding the antibacterial mechanisms of action of silver nanocomposites from C. macrostachyus-based activated carbon may contribute to our understanding of the antibacterial action of these biomaterials. Nevertheless, more chemistry and in vivo experiments as well as in depth antibacterial mechanistic studies are warranted for the successful utilization of these antibacterial biomaterials.

25 October 2023 in Preprints.org
Verified
Preprint
Open access
PDF file
LTLoic Franklin Tchinda Taghu
Loic Franklin Tchinda Taghu
PBPone Kamdem Boniface
Pone Kamdem Boniface
VNVincent Ngouana
Vincent Ngouana
TYTanka Zuriatou Zuriatou Yajeh
Tanka Zuriatou Zuriatou Yajeh
VYVictorine Lorette YIMGANG
Victorine Lorette YIMGANG
FBFabrice Fekam Boyom
Fabrice Fekam Boyom
In this study, we report the antibacterial mechanisms of action of uniform silver nanoparticles (AgNPs) and decorated activated carbon nanocomposite (CAC-AgNPs) obtained using a green synthesis approach. The nanomaterials were characterized by ultraviolet-visible (UV-vis) absorption spectra and Fourier transform infrared (FTIR) spectra. The antibacterial activity of the as-prepared nanomaterials was evaluated against an array of bacterial strains by microdilution method, whereas their cytotoxicity profile was evaluated on Vero cells (human mammalian cells). The antibacterial mechanistic studies of active nanomaterials were carried out through bacterial growth kinetics, nucleic acid leakage test, and catalase inhibition assay. A silver nanocomposite was successfully fabricated from Croton macrostachyus-based activated carbon. The as-prepared nanomaterials exhibited antibacterial activity against an array of bacterial strains (minimum inhibitory concentration (MIC) range: 62.5 to 500 µg/mL), the most susceptible being Escherichia coli and Staphylococcus aureus. Cytotoxicity studies of the nanomaterials on Vero cells revealed that the nanocomposite (median cytotoxic concentration (CC50): 213.6 µg/mL) was less toxic than the nanoparticles (CC50 value: 164.75 µg/mL) counterpart. Antibacterial mechanistic studies unveiled that the nanomaterials induced (i) bacteriostatic activity vis-à-vis E. coli and S. aureus and (ii) inhibition of catalase in these bacteria. This novel contribution on the antibacterial mechanisms of action of silver nanocomposite from C. macrostachyus-based activated carbon might contribute to the understanding of antibacterial action of these biomaterials. Nevertheless, more chemistry and in vivo experiments, as well as in depth antibacterial mechanistic studies are warranted for the successful utilization of these antibacterial biomaterials.

15 November 2026 in Journal of Drug Delivery and Therapeutics
Verified
Journal Article
Open access
PDF file
VYVictorine Lorette YIMGANG
Victorine Lorette YIMGANG
Brice Rostan PinlapBrice Rostan Pinlap
Brice Rostan Pinlap
ETEbenezer Foka Tatiekam
Ebenezer Foka Tatiekam
ESEmmanuel Souana
Emmanuel Souana
PDPierre Michel Jazet Dongmo
Pierre Michel Jazet Dongmo
FBFabrice Fekam Boyom
Fabrice Fekam Boyom
Introduction and objective: Antimicrobial resistance in Staphylococcus aureus represents a major public health concern, highlighting the need for new antibacterial agents. Endophytic fungi associated with medicinal plants are promising sources of bioactive secondary metabolites for this purpose. This study therefore aimed to evaluate the antibacterial activity and investigate the modes of action of two ethyl acetate extracts of endophytic fungi isolated from Annona muricata seeds, against a resistant strain Staphylococcus aureus NR-46003. Methods: The broth microdilution method was used to determine the Minimum Inhibitory Concentrations (MICs) while the effects of the extracts on bacterial growth were assessed by growth kinetics. Additional assays examined cellular protein content, ethidium bromide accumulation, glucose-induced extracellular acidification and antibiofilm activity. Results: Both fungal extracts exhibited pronounced antibacterial potency, with MICs of 25 μg/mL and 12.5 μg/mL for P. citrinum AMs3 and Aspergillus sp. AMs9, respectively. Growth kinetics showed concentration-dependent inhibition, with complete suppression of visible growth at the MIC and higher concentrations over 24 h. Both extracts reduced cellular protein content, increased ethidium bromide retention, and attenuated glucose-induced extracellular acidification, findings consistent with effects on protein biosynthesis, efflux activity and proton transport. Moreover, both extracts demonstrated substantial antibiofilm activity, inhibiting biofilm formation by up to 73.63% and eradicating established biofilms by up to 64.71%. Conclusion: These findings provide compelling evidence supporting the pharmacological exploitation of P. citrinum AMs3 and Aspergillus sp. AMs9 as promising lead candidates for the development of innovative therapeutic interventions against resistant S. aureus infections. Keywords: Antimicrobial resistance, Penicillium citrinum AMs3, Aspergillus sp. AMs9.